Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed May 11, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0001346824-26-000127)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-05-11

Form type: SCHEDULE 13G
Filing date: May 11, 2026
Accession number: 0001346824-26-000127
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)